Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma
Journal of Clinical Medicine Research · 2023-02 · 15 (2) · 68-75
DOI: 10.14740/jocmr4853 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine Research, 2023-02. Verfasst von Takuma Hayashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Hospital Organization Kyoto Medical Center, Fukakusa Mukaihata-cho, Kyoto 612-8555, Japan. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Hospital Organization Kyoto Medical Center, Fukakusa Mukaihata-cho, Kyoto 612-8555, Japan.
- Kyoto University, Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan.
ORCID-Profile: Takuma Hayashi, Ikuo Konishi
Zitieren
APA
Hayashi, T., & Konishi, I. (2023). Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma. Journal of Clinical Medicine Research, 15(2), 68-75. https://doi.org/10.14740/jocmr4853
Vancouver
Hayashi T, Konishi I. Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma. Journal of Clinical Medicine Research. 2023;15(2):68-75. doi:10.14740/jocmr4853
BibTeX
@article{Hayashi2023,
author = {Hayashi, Takuma and Konishi, Ikuo},
title = {Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma},
journal = {Journal of Clinical Medicine Research},
year = {2023},
volume = {15},
number = {2},
pages = {68--75},
doi = {10.14740/jocmr4853}
}
EUVIMED